Sutent (sunitinib malate)

pCPA File Number: 20751

Negotiation Status:

Concluded with an LOI

Indication(s):

Pancreatic Neuroendocrine Tumors

Sponsor/Manufacturer:

Pfizer Canada ULC

CDA-AMC Project Number:

PC0004-000

pCPA Engagement Letter Issued:

2012-12-01

Negotiation Process Concluded:

2013-08-14